Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.
Roccaro AM, Sacco A, Husu EN, Pitsillides C, Vesole S, Azab AK, Azab F, Melhem M, Ngo HT, Quang P, Maiso P, Runnels J, Liang MC, Wong KK, Lin C, Ghobrial IM.
Roccaro AM, et al. Among authors: lin c.
Blood. 2010 Jan 21;115(3):559-69. doi: 10.1182/blood-2009-07-235747. Epub 2009 Nov 19.
Blood. 2010.
PMID: 19965685
Free PMC article.